Showing results (101-110 of 121) with videos related to
Sort By:
Pageof 13
Leukemia|January 1, 1991
ProMACE-cytaBOM versus MACOP-B in intermediate and high grade NHL. Preliminary results of a prospective randomized trialM Federico, G Moretti, P G Gobbi, et al.Acta Bio-Medica De L'Ateneo Parmense : Organo Della Societa Di Medicina E Scienze Naturali Di Parma|January 1, 1982
[Disturbances of equilibrium in the aged]C Rizzi, G Moretti, E Anesi, et al.Minerva Pediatrica|October 20, 2007
[Organisational aspects of a donated breast milk bank: experience of the Treviso hospital]A Paccagnella, S Michieletto, I Pitassi, et al.Parasitology|October 10, 2007
Anti-Trypanosoma cruzi effects of cyclosporin A derivatives: possible role of a P-glycoprotein and parasite cyclophilinsJ Búa, L E Fichera, A G Fuchs, et al.European Review for Medical and Pharmacological Sciences|March 1, 2003
ERCP and acute pancreatitisF Fiocca, A Santagati, V Ceci, et al.Biomaterials|December 26, 2009
In vitro generation of mechanically functional cartilage grafts based on adult human stem cells and 3D-woven poly(epsilon-caprolactone) scaffoldsPiia K Valonen, Franklin T Moutos, Akihiko Kusanagi, et al.Cancer Chemotherapy and Pharmacology|February 5, 2013
The Breast Avastin Trial: phase II study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancerG Bisagni, A Musolino, M Panebianco, et al.Annals of Clinical and Laboratory Science|March 1, 1996
Immunity status to polioviruses among non-European union immigrants in Veneto Region (North-East Italy)R Trivello, T Ngatchu, V Marin, et al.Tumori|November 1, 1996
Neoadjuvant chemotherapy with continuous infusion of cisplatin and fluorouracil in stage II-IV, M0 squamous cell carcinoma of the head and neckC Boni, G Moretti, L Savoldi, et al.International Journal of Cancer|August 5, 2000
Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: a phase II study of the italian oncology group for clinical research (GOIRC)C Boni, G Bisagni, L Savoldi, et al.Pageof 13